1. Home
  2. PROF vs PRQR Comparison

PROF vs PRQR Comparison

Compare PROF & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

N/A

Current Price

$7.52

Market Cap

230.4M

Sector

Health Care

ML Signal

N/A

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

N/A

Current Price

$2.19

Market Cap

250.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PROF
PRQR
Founded
N/A
2012
Country
Canada
Netherlands
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.4M
250.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PROF
PRQR
Price
$7.52
$2.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$11.00
$8.14
AVG Volume (30 Days)
150.0K
639.0K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,297,000.00
$18,859,556.00
Revenue This Year
$64.23
N/A
Revenue Next Year
$113.06
$19.56
P/E Ratio
N/A
N/A
Revenue Growth
67.94
N/A
52 Week Low
$3.76
$1.07
52 Week High
$7.99
$3.10

Technical Indicators

Market Signals
Indicator
PROF
PRQR
Relative Strength Index (RSI) 58.87 49.89
Support Level $7.02 $2.03
Resistance Level $7.60 $2.25
Average True Range (ATR) 0.39 0.17
MACD -0.02 0.00
Stochastic Oscillator 65.52 41.76

Price Performance

Historical Comparison
PROF
PRQR

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: